bpc 157 what's in it BPC-157 Benefits, Dosage & Before/After Results How does the peptide BPC-157

10.4049/jimmunol.174.3.1491

It also states that available safety information is insufficient to know whether harm could occur

The mechanism of action has been determined that KPV inhibits the activation of NF-kappaB and MAP kinase inflammatory signaling pathways, and reduces pro-inflammatory cytokine secretionacts via PepT1 expressed in immune and intestinal epithelial cells..[and] reduces the incidence of DSS- and TNBS-induced colitis indicated by a decrease in pro-inflammatory cytokine expression (Dalmasso et al., 2008)

Weve talked about the dosing and such

It is classified as a Category 2 bulk drug substance by the FDA, which restricts its availability through compounding pharmacies